|
Base case
|
4889
|
|
Screening characteristics
| |
|
Under hypothetical improved cervical screening program**
|
6167
|
|
Vaccine characteristics
| |
|
Assuming no HPV 6/11 protection
|
5771
|
|
Duration of protection = 20 years
|
8090
|
|
Vaccination characteristics
| |
|
Low vaccine coverage (70%)
|
4444
|
|
High vaccine coverage (95%)
|
5212
|
|
Costs characteristics
| |
|
Cost of diagnosis and treatment +20%
|
4744
|
|
Cost of diagnosis and treatment −20%
|
5037
|
|
Cost of vaccine - 10%
|
4351
|
|
Cost of vaccine + 10%
|
5454
|
|
Health utility values
| |
|
Cost per life year saved (no quality of life adjustments)
|
6746
|
|
Discount rate
| |
|
Discount rate 0%
|
1517
|
|
Discount rate 5%
|
11148
|
